Using Molecular Symmetry to Form New Drugs: Hydroxymethyl-Substituted 3,9-Diazatetraasteranes as the First Class of Symmetric MDR Modulators

More is not always better: Until now it was considered that modulators of P‐glycoprotein‐associated multidrug resistance in cancer treatment showed greater inhibitory activity with an increasing number of moieties that could participate in hydrogen bonds. This theory has been questioned for the firs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Angewandte Chemie International Edition 2002-10, Vol.41 (19), p.3623-3625
Hauptverfasser:	Hilgeroth, Andreas, Molnár, Jósef, De Clercq, Eric
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology ATP Binding Cassette Transporter, Sub-Family B - antagonists & inhibitors ATP Binding Cassette Transporter, Sub-Family B - metabolism cage compounds Drug Design Drug Resistance, Multiple Drug Resistance, Neoplasm Heterocyclic Compounds - chemical synthesis Heterocyclic Compounds - chemistry Heterocyclic Compounds - pharmacology MDR modulators medicinal chemistry Mice Molecular Structure photochemistry structure-activity relationships Tumor Cells, Cultured
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!